Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATYR | AZN | AMGN | GILD | GSK |
| Company | Atyr Pharma Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.8620 | 203.40 | 351.60 | 140.70 | 59.07 |
| High | 0.8620 | 203.40 | 351.60 | 140.70 | 59.07 |
| Low | 0.8620 | 203.40 | 351.60 | 140.70 | 59.07 |
| Latest | 0.8620 | 203.62 | 350.52 | 140.43 | 59.06 |
| Change | +0.0211 | -0.76 | -0.43 | -0.02 | -0.12 |
| % Change | +2.51% | -0.37% | -0.12% | -0.01% | -0.20% |
| Volume | 4,086 | 13,793 | 940 | 1,023 | 10,639 |
| 20-Day Average Volume | 947,249 | 1,829,275 | 2,679,287 | 5,885,901 | 4,090,752 |
| Previous Close | 0.8409 | 204.38 | 350.95 | 140.45 | 59.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8068 | 195.60 | 349.83 | 139.10 | 55.46 |
| 20-Day Raw Stochastic | 81.84% | 84.34% | 64.55% | 68.75% | 93.77% |
| 20-Day Relative Strength | 51.66 | 57.67 | 47.58 | 49.78 | 62.96 |
| Weighted Alpha | +4.70 | +49.63 | +26.05 | +34.17 | +66.73 |
| Today's Opinion | 56% Sell | 88% Buy | 56% Buy | 56% Buy | 88% Buy |
| Previous Opinion | 56% Sell | 88% Buy | 56% Buy | 56% Buy | 88% Buy |
| Last Month's Opinion | 16% Sell | 56% Buy | 88% Buy | 88% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.78% since 04/08/26 | -0.43% since 04/08/26 | +0.51% since 04/08/26 | -0.59% since 04/08/26 | +2.96% since 04/08/26 |
| Low | 0.7500 on 04/09/26 | 200.70 on 04/13/26 | 345.41 on 04/14/26 | 137.02 on 04/13/26 | 57.01 on 04/09/26 |
| High | 0.8750 on 04/14/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 59.57 on 04/14/26 |
| 1-Month | |||||
| %Chg | +1.41% since 03/13/26 | +7.11% since 03/13/26 | -3.99% since 03/13/26 | -2.96% since 03/13/26 | +10.64% since 03/13/26 |
| Low | 0.7200 on 03/30/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 51.54 on 03/20/26 |
| High | 0.9098 on 03/17/26 | 207.30 on 04/10/26 | 370.89 on 03/16/26 | 146.71 on 03/17/26 | 59.57 on 04/14/26 |
| 3-Month | |||||
| %Chg | +22.01% since 01/15/26 | +8.20% since 01/15/26 | +6.54% since 01/15/26 | +16.03% since 01/15/26 | +20.26% since 01/15/26 |
| Low | 0.6701 on 01/28/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.10 on 01/16/26 | 47.62 on 01/20/26 |
| High | 1.1100 on 02/19/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | -15.49% since 10/15/25 | +19.89% since 10/15/25 | +18.26% since 10/15/25 | +18.93% since 10/15/25 | +34.92% since 10/15/25 |
| Low | 0.6400 on 11/21/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.85 on 10/24/25 |
| High | 1.1100 on 02/19/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 82,451 | 316,974,592 | 189,402,464 | 174,329,632 | 120,222,808 |
| Shares Outstanding, K | 98,051 | 1,550,908 | 539,685 | 1,241,222 | 2,031,477 |
| Annual Sales | 190,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | -74,120,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 190,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,424,970,000 |
| Last Quarter Net Income | -25,740,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 851,670,000 |
| 60-Month Beta | 0.64 | 0.35 | 0.47 | 0.39 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.14 on 03/05/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.68 on 02/04/26 |
| Latest Earnings Date | 05/06/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.470 on 02/20/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.08 | 16.01 | 17.06 | 13.04 |